Citations

Showing 10 of 108094 citations.

Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn’s Disease: An International Multicenter Study
Calabrese, Emma , Kucharzik, Torsten , Maaser, Christian , Strobel, Deike , Zorzi, Francesca, Novak, Kerri L. , Bruining, David H. , Iacucci, Marietta , Watanabe, Mamoru , Lolli, Elisabetta , Chiaramonte, Carlo, Pallone, Francesco, Ghosh, Subrata , Monteleone, Giovanni , Wilson, Stephanie R, Maconi, Giovanni , Wilson, Stephanie R. , Hanauer, Stephen B. , Panaccione, Remo , Iacucci, Marietta

Mayo Clinic

Inflammatory Bowel Diseases | April 28, 2018 | Volume: 24 | Issue: 9 | Pages: 2001-2006

10.1093/ibd/izy091 | PMID 29718450 Get It

A cross-sectional study of learning styles among continuing medical education participants
Collins, C. Scott, Nanda, S. , Palmer, Brian A. , Mohabbat, Arya B. , Schleck, Cathy D. , Mandrekar, Jayawant N. , Mahapatra, Saswati , Beckman, Thomas J. , Wittich, Christopher M. , Nanda, Sanjeev

Mayo Clinic

Medical Teacher | April 28, 2018 | Volume: 41 | Issue: 3 | Pages: 318-324

10.1080/0142159x.2018.1464134 | PMID 29703093 Get It

Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis
Jitprapaikulsan, Jiraporn , López‐Chiriboga, A. Sebastian , Fryer, James P., McKeon, Andrew , Weinshenker, Brian G. , Pittock, Sean J. , Pittock, S J , Weinshenker, Brian G , McKeon, Andrew , Flanagan, Eoin P.

Mayo Clinic

JAMA Neurology | April 28, 2018 | Volume: 75 | Issue: 7 | Pages: 892

10.1001/jamaneurol.2018.0805 | PMID 29710213 Get It

Fibroblast Growth Factor Receptor Inhibition for Cholangiocarcinoma: Looking Through a Door Half‐Opened
Ilyas, Sumera I., Ilyas, Sumera I., Gores, Gregory J.

Mayo Clinic

Hepatology | April 28, 2018 | Volume: 68 | Issue: 6 | Pages: 2428-2430

10.1002/hep.30069 | PMID 29704257 Get It

Interobserver Variability of Sonographic Features Used in the American College of Radiology Thyroid Imaging Reporting and Data System
Middleton, William D. , Farjat, Alfredo E. , Teefey, Sharlene A. , Abinanti, Nicole, Boschini, Fernando J., Bronner, Abraham J., Dahiya, Nirvikar , Hertzberg, B S, NEWMAN, J. , Scanga, Daniel, Vogler, Robert C., Tessler, Franklin N. , Hoang, Jenny K.

Mayo Clinic

American Journal of Roentgenology | April 27, 2018 | Volume: 211 | Issue: 1 | Pages: 162-167

10.2214/ajr.17.19192 | PMID 29702015 Get It

Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma
Shah, Paras , Thompson, R. Houston, Boorjian, Stephen A. , Lohse, Christine M. , Lyon, Timothy D. , Shields, Raymond C., Froehling, David A. , Leibovich, Bradley C. , Froehling, David, Viers, Boyd R. , Lyon, Timothy D

Mayo Clinic

Journal of Urology | April 27, 2018 | Volume: 200 | Issue: 3 | Pages: 520-527

10.1016/j.juro.2018.04.069 | PMID 29709665 Get It

Outcomes and Prognostic Factors in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Recurrence after Radical Prostatectomy
Ravi, Praful , Karnes, R. Jeffrey , Rangel, Laureano J. , Pagliaro, Lance C.

Mayo Clinic

Journal of Urology | April 27, 2018 | Volume: 200 | Issue: 5 | Pages: 1075-1081

10.1016/j.juro.2018.04.070 | PMID 29709664 Get It

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma
LaCasce, Ann S. , Bociek, R. Gregory , Sawas, Ahmed , Caimi, Paolo, Agura, Edward, Matous, Jeffrey, Ansell, Stephen M. , Crosswell, Howland E. , Islas‐Ohlmayer, Miguel, Behler, Caroline, Cheung, Eric, Forero‐Torres, Andres , O’Connor, Owen A. , Josephson, Neil C. , Advani, Ranjana H. , Advani, Ranjana H , Vose, Julie M. , Wang, Yinghui

Mayo Clinic

Blood | April 27, 2018 | Volume: 132 | Issue: 1 | Pages: 40-48

10.1182/blood-2017-11-815183 | PMID 29703778 Get It

Key PointsThe outpatient BV and bendamustine regimen is highly active as first salvage therapy in relapsed/refractory HL, with manageable toxicity. The CR rate of 73.6% exceeded those reported for standard chemotherapy regimens, and post-ASCT outcomes generally appeared excellent.
Parental Views on Fetal Intervention in Down's Syndrome [1I]
Allyse, Megan , Allyse, Megan A

Mayo Clinic

Obstetrics & Gynecology | April 27, 2018 | Volume: 131 | Issue: 1 | Pages: 97S-97S

10.1097/01.aog.0000533429.63815.e3 Get It

INTRODUCTION: Clinical trials for fetal surgery and gene therapy interventions in fetuses identified as having trisomy 21 (Down syndrome) have shown increasing success in human and animal models. These interventions vary from physical intercessions, such as cardiac repairs, to attempts at cognitive improvement, including retention and learning ability. However, these interventions have been controversial among family members and individuals living with Down syndrome. In particular, community members have argued that attempts to intervene in the natural progression of Down syndrome contravene efforts to encourage acceptance and support of individuals with Down syndrome. METHODS: We conducted a nation-wide, online survey of parents of individuals with Down syndrome about their opinions and willingness to accept prenatal interventions in pregnancies with Down syndrome. RESULTS: Parents were sharply divided on the acceptability of fetal interventions in pregnancies with Down syndrome. Parents expressed conflicts between the desire to give children every possible opportunity and the need and willingness to accept their children as they were and as complete individuals in their own right. A significant percentage reported that they would refuse prenatal gene therapy for potential cognitive intervention in pregnancies with Down syndrome. CONCLUSION: Significant investment is ongoing in the detection of and intervention in pregnancies affected by aneuploidies such as Down syndrome. This study emphasizes the need to include broader stakeholder populations, including families of existing individuals, in the development and translation of such therapies. Significant rejection from patient advocate populations may result from a lack of engagement.
Bimanual Pelvic Examination is Not Sensitive for Fibroid Diagnosis [30G]
Green, Isabel, Laughlin-Tommaso, Shannon K., Ahmed, Farah K. , Green, Isabel C. , Stewart, Elizabeth A.

Mayo Clinic

Obstetrics & Gynecology | April 27, 2018 | Volume: 131 | Issue: 1 | Pages: 83S-83S

10.1097/01.aog.0000533380.96988.0c Get It

INTRODUCTION: Bimanual pelvic examination is often performed for symptoms related to uterine fibroids (UF). We evaluated the clinical utility of this exam at the time of UF diagnosis in a community setting. METHODS: Retrospective sample of women diagnosed with UF between 2006 and 2010 in the Rochester Epidemiology Project, a population-based records-linkage system. Cohort includes a sample of women who had a pelvic examination within 12 months of UF diagnosis (n=141). Abnormal pelvic exam was defined as abnormal uterine size or shape, or any adnexal mass or fullness recorded by healthcare provider. We examined clinical and imaging characteristics using chi-squared for categorical and t tests for continuous data. Data reported as percentage or mean ± standard deviation. Volumes of the uterus and largest fibroid were calculated using the prolate ellipsoid formula. RESULTS: Women with UF and a normal pelvic exam (n=73) were younger than women with abnormal exam (n=68) (44.7±7.1 vs 46.9±5.4 years, P=.05), and had a higher BMI (29.4 ± 6.5 vs 26.6 ± 5.0 kg/m2, P=.007). Women with abnormal exam had significantly larger uterine volumes (226.0 ± 151.8 vs 150.9 ± 97.9 cm³, P=.005) and fibroid volumes (61.1±81.1 vs 19.9±52.8 cm³, P=.005). Abnormal examination was more frequently documented by gynecology providers (57.4%) than other providers (42.7%, P=.04). Fibroid symptoms were not associated with abnormal examination. CONCLUSION: Fifty-two percent of women with fibroids had a normal bimanual examination. Thus, a high suspicion of fibroids should prompt imaging. Lower BMI and larger uterine and fibroid dimensions increase fibroid diagnosis on pelvic examination.